Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter Retrospective Turkish Oncology Group trial.

dc.contributor.authors	Yildiz I, Ekenel M, Akman T, Kocar M, Uysal M, Kanitez M, Varol U, Bayoglu IV, Tural D, Kaplan MA, Avci N, Sürmeli Z, Dede İ, Ulaş A, Yazici O, Basaran M
dc.date.accessioned	2020-02-27T08:41:18Z
dc.date.available	2020-02-27T08:41:18Z
dc.date.issued	2014
dc.identifier.citation	Yildiz I, Ekenel M, Akman T, Kocar M, Uysal M, Kanitez M, Varol U, Bayoglu IV, Tural D, Kaplan MA, Avci N, Sürmeli Z, Dede İ, Ulaş A, Yazici O, Basaran M (2014). Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter Retrospective Turkish Oncology Group trial.. Anticancer Res. , 34(8, 34-4329
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66720
dc.title	Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter Retrospective Turkish Oncology Group trial.
dc.identifier.volume	34(8
dc.identifier.startpage	4329
dc.identifier.endpage	34
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	Anticancer Res.
dc.contributor.author	Bayoğlu, İbrahim Vedat